Summary
In a patient affected by acute lymphoblastic leukemia (ALL) and subjected to therapy withErwinia l-asparaginase, acute parotitis was observed. Microbiological studies excluded any infectious etiology. Regression of parotitis was spontaneous. This complication has not been previously reported and could be due to the same mechanism of pancreatic injury. The occurrence of acute parotitis needs to be promptly recognized in order to avoid the continuation ofl-asparaginase.
Similar content being viewed by others
References
Adams LJ, Antonow DR, Ash R, McClain C (1985) Salivary hyperamylasemia afterl-asparaginase therapy. Cancer Treat Rep 69:1437–1438
Dolowy WC, Henson D, Cornet J et al. (1966) Toxic and antineoplastic effects ofl-asparaginase: study of mice with lymphoma and normal monkeys and report on a child with leukemia. Cancer 19:1813–1819
Eden OB, Lilleyman J, Shaw MP, Richards S, Peto J (1987) Medical Research Council Childhood Leukemia Trial VIII compared with trials II–VII: lessons for future management. Haematol Blood Transfus 30:1–8
Eden OB, Shaw MO, Lilleyman JS, Richards S (1990) Non-randomized study comparing the toxicity ofEscherichia coli andErwinia asparaginase in children with leukemia. Med Pediatr Oncol 18:487–502
Hall JG (1970) The partition ofl-asparaginase between blood and lymph. Cancer Res 33:75–80
Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Block JB, Serpick AA, Selawry OS (1969)l-asparaginase.Therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 281:1028–1034
Hill JM, Roberts J, Loeb E et al. (1967)l-asparaginase therapy for leukemia and other malignant neoplasms. JAMA 202:882–888
Humphries JE, Lee JT (1992) Acute bilateral parotitis during chemotherapy for acute lymphoblastic leukemia. Acta Haematol 88:55–56
Kidd JG (1953) Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kind in mice and rats given guinea pig serum, horse serum or rabbit serum. J Exp Med 98:565–582
King OY, Wilbur JR, Mumford DM et al. (1974) Therapy withErwinia l-asparaginase in children with acute leukemia after anaphylaxis toE. coli l-asparaginase. Cancer 33:661–664
Murakawa M, Okamura T, Shibuya T, Harada M, Otsuka T, Niho Y (1992) Use of a synthetic protease inhibitor for the treatment ofl-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation. Ann Hematol 64:249–252
Schneyer CA, Galbraith WM (1975) Inhibition of cyclotydine-induced enlargement of parotid and heart by propanolol or sympathectomy. Proc Soc Exp Biol Med 150:394–400
Shpilberg O, Ra'anani PR, Ben-Bassat I, Ramot B (1991) Recurrent bilateral parotitis in acute myeloid leukemia. Acta Hematol 86:56
Steer ML, Meldolesi J, Figarella C (1984) Pancreatitis: the role of lysosomes. Dig Dis Sci 29:934
Tallal L, Tan C, Oettgen H et al. (1969)l-asparaginase in 111 children with leukemias and solid tumors. Proc Am Soc Ass Cancer Res 10:92
Thompson AG (1968) Proteinase inhibitors in experimental and clinical pancreatitis. Ann NY Acad Sci 146:540
Whitecar JP Jr, Bodey GP, Harris JE, Freireich EJ (1970)l-asparaginase. N Engl J Med 26:732–734
Zubrod CG (1970) The clinical toxicities ofl-asparaginase in the treatment of leukemia and lymphoma. Pediatrics 45:555–559
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sica, S., Pagano, L., Salutari, P. et al. Acute parotitis during induction therapy includingl-asparaginase in acute lymphoblastic leukemia. Ann Hematol 68, 91–92 (1994). https://doi.org/10.1007/BF01715139
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01715139